Point mutations are classified by their effect: silent (synonymous) mutations change the codon but not the amino acid, missense mutations change the amino acid (potentially affecting protein function), and nonsense mutations create stop codons (producing truncated proteins). The impact depends on the amino acid's location, properties of the substituted amino acid, and the protein's functional constraints. Evolutionary studies reveal that ~25% of missense mutations are neutral, while ~73% are slightly deleterious.
From your understanding of the genetic code, you know that 64 codons encode 20 amino acids plus stop signals, meaning the code is degenerate — most amino acids are specified by multiple codons. This redundancy is not random; it is structured in a way that profoundly shapes how single-nucleotide changes affect protein products. A silent (synonymous) mutation changes a codon to another codon for the same amino acid. For example, GCU, GCC, GCA, and GCG all encode alanine, so a mutation at the third position often produces no change in the protein. These mutations were long considered truly "neutral," but we now know they can subtly affect gene expression by altering mRNA folding, stability, or translation speed through codon usage bias.
A missense mutation substitutes one amino acid for another. Whether this matters depends critically on context. A conservative substitution — replacing one amino acid with a chemically similar one (say, leucine for isoleucine, both hydrophobic) — in a non-critical region of the protein may have no detectable effect on function. But the same substitution in the active site of an enzyme, at a protein-protein binding interface, or in a structurally critical position can be devastating. The classic example is sickle cell disease: a single missense mutation changes the sixth amino acid of β-globin from glutamic acid (hydrophilic, charged) to valine (hydrophobic), causing hemoglobin molecules to polymerize under low-oxygen conditions and deform red blood cells. The severity of a missense mutation thus depends on three factors: the position in the protein, the chemical difference between the original and substituted amino acid, and the protein's tolerance for structural variation.
A nonsense mutation converts an amino acid codon into one of the three stop codons (UAA, UAG, or UGA), prematurely terminating translation. The result is a truncated protein missing everything downstream of the mutation site. In most cases, truncated proteins are nonfunctional — they lack essential domains — and are often recognized and degraded by the cell's quality control system, nonsense-mediated mRNA decay (NMD). NMD detects premature stop codons and destroys the mRNA before much truncated protein accumulates, effectively converting the mutation into a null allele. The location of the nonsense mutation matters: one near the end of the gene may produce a nearly full-length protein that retains partial function, while one near the beginning eliminates the protein entirely.
Evolutionary analysis provides a powerful lens for understanding these mutation types. Across species, sites that are functionally constrained accumulate fewer non-synonymous substitutions than synonymous ones — the signature of purifying selection removing harmful changes. The finding that roughly 73% of missense mutations are slightly deleterious explains why non-synonymous substitution rates are consistently lower than synonymous rates across genes. Conversely, genes under strong functional constraint (like histones, which interact with every other protein in the nucleus) tolerate almost no missense mutations, while genes under weaker constraint (like olfactory receptors in species that rely less on smell) accumulate them more freely. Understanding this spectrum — from silent to missense to nonsense — is essential for interpreting the clinical significance of variants found through genetic testing and genome sequencing.